Jing Li

Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study.

Ying Cheng, Jianming Xu, L. Shen, 2020, The Lancet. Oncology.

Real world outcomes of lenalidomide or bortezomib maintenance in patients with multiple myeloma not undergoing stem cell transplantation

Peng Liu, Tianhong Xu, Jiadai Xu, 2023, Annals of Hematology.

Differences and similarities in clinical pharmacy practice in China and the United States: a narrative review

Zhiping Li, Jing Li, 2017, European journal of hospital pharmacy. Science and practice.

The evolving diagnosis and treatment paradigms of multiple myeloma in China: 15 years' experience of 1256 patients in a national medical center

Peng Liu, Tianhong Xu, Jiadai Xu, 2023, Cancer Medicine.

Thrombosis events in Chinese patients with newly diagnosed multiple myeloma

Peng Liu, Tianhong Xu, Jiadai Xu, 2023, Clinical and Experimental Medicine.